Principal Investigator
Matthew Schlumbrecht
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231060
Clinical Trial Summary
A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647